Fusidic acid for ophthalmic infections: a review of clinical and cost effectiveness and safety
CADTH
Record ID 32014000206
English
Authors' recommendations:
Short term (seven day) treatment with topical fusidic acid resolved clinical signs and symptoms of conjunctivitis or chronic blepharitis in 76% to 91% of patients. Fusidic acid cure rates were not statistically significantly different than topical tobramycin, norfloxacin or ciprofloxacin based on three lower quality randomized controlled trials. Ocular discomfort and irritation were the most frequent adverse events associated with topical antibiotics. No data were available on the cost-effectiveness of fusidic acid for the treatment of ocular infections.
Details
Project Status:
Completed
Year Published:
2013
URL for published report:
http://www.cadth.ca/media/pdf/htis/feb-2013/RC0430%20Fucidic%20Acid%20Draft%20Final.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Humans
- Fusidic Acid
- Ophthalmic Solutions
- Conjunctivitis, Bacterial
- Blepharitis
- Child
- Child, Preschool
- Adolescent
- Adult
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.